Our Journals

1.Types of Articles

Review Articles:

A review article should normally occupy less than 16 pages. In reviewing the literature, the authors are urged to evaluate validity of conclusions based upon the appropriateness of statistical design of the experiment. The help of a statistician is highly recommended. Lastly, the reviewers should refrain from introducing personal bias or opinion that cannot be supported experimentally.

Research Articles:

The length of the research article should not exceed 8 pages, including all figures and tables.

The text of articles reporting original research is usually divided into Introduction, Methods, Results, and Discussion sections (IMRAD) Short Communications:

Short communications should be prepared like research articles except the text should not be divided into subheading and the length should not exceed 4 pages.

Letters to the Editor:

This section is designed to provide a forum for the exchange of practical information, advice and opinions in response to a published article. The opinions and advice expressed are not necessarily those of the editors of the Journal, and publication will be at the editors' discretion.

2.Calculation of Manuscript Size:

One page contains approximately 880 words, two or three figures or tables, or 34 references.

3.How to Submit the Manuscript online or by e-mail

Prepare a single file of the manuscript in both WORD and PDF. The manuscript should contain the following information in the order below.




A) TITLE




B) AUTHOR (First name followed by middle name, if any, and last or family name) & AFFILIATION(S) CONTINUE IF MORE THAN ONE AUTHOR




C) ABSTRACT (< 200 WORDS)




D) KEY WORDS (6-8)




E) CORRESPONDING AUTHOR (only one) WITH ADDRESS AND E-MAIL (All correspondence must come from this author only).




F) INTRODUCTION




G) MATERIALS AND METHODS




H) RESULTS




I) DISCUSSION




J) CONCLUSION




K) ACKNOWLEDGEMENT (If any)




L) CONFLICT OF INTEREST




M) REFERENCES (Must follow journal style described below. If not, manuscript will be returned)




N) TABLE(S) (If any). Type title followed by the table.




O) FIGURE(S) (If any). Type Figure legend followed by figure. Do not insert figure legend inside figure.




To submit a manuscript, go to http://www.nchpjournals.com/
Click Submit Manuscript button on top right side of the page
Sign in with your email address and password.
After login, please select journals (CTNR/IJPP) from left side menu.
Click Submit Manuscript, enter all required details and submit.
Alternatively, you can submit your manuscript by e-mail to: nchpjournals@gmail.com

4. Article Processing Charges

The New Century Health Publishers introduces 100% open access publishing of manuscript submitted to the CTNR in 2025 for a fee based on WORLD BANK INCOME DATA of the country. The accepted manuscripts will be published on the journal website within 5 days of acceptance, galley-proof approval and fee payment. For the years 2025 and 2026, the maximum publication fee is set at US$1000 per manuscript. This fee will include services such as minor grammar and language checks followed by typesetting, copy editing, posting with indexing services, and DOI assignment. If the manuscript needs additional help with writing and content presentation, we offer this service at a rate ranging between $200 and 600 per manuscript to be determined by manuscript size. Please note that we help but do not organize references. There will be no charge for color illustration.

The publisher will grant full to partial waiver of the publication fee for select accepted manuscript from economically stressed countries (based on WORLD BANK INCOME DATA) on a case-by-case basis for non-funded research. The maximum waiver fund is currently limited to $5,000 each year. Please contact (Mrs.) SK Gupta at nchpjournals@gmail.com for waiver enquiry.

5. Proofs:

The corresponding author will receive the galley-proof by e-mail in PDF format for correction, and these must be returned to the printer within 48 hours of receipt. Cost of unreasonable alterations of the original composition will be charged to authors.

6. Copyright:

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Authors are required to complete a copyright transfer agreement and submit it with the final version of the accepted manuscript.

Organization of Manuscript

Papers should be typed in Times Roman, double-spaced with 1-inch-wide margins. Please do not insert Tables and Figures in the text.

i. Title Page:

This is the first page of the manuscript. This page MUST provide the following information in the order as outlined below.br>

• Title of the manuscript
• The title provides a distilled description of the complete article and should include information that, along with the abstract, will make electronic retrieval of the article relevant and specific. Reporting guidelines recommend information about the study design be a part of the title (particularly for randomized trials, systematic reviews and meta-analyses).

ii) Surname (family name) followed by initials of the first author (Example: Doe, J. E.)
iii) Mailing address, Telephone & FAX numbers and e-mail address of the first author
iv) Follow steps ii) and iii) for additional authors. Request for permission to add, delete or change of sequence of authors of the manuscript should be made to the Editor-in-Chief prior to acceptance of the manuscript. The request must be made in writing and ALL authors must sign it, The Editor-in-Chief reserves the right to reject the request.
v) Designate the author to whom correspondence should be addressed, along with telephone and FAX numbers and an E-mail address.
vi) The title page should also indicate the number of manuscript pages, figures (Black & White and in color), and tables.
vii) Four to six keywords should be listed in alphabetical order
viii) A Running Title not to exceed 35 characters
ix)Each author's highest academic degrees can be listed. The name of the department(s) and institution(s) or organizations where the work should be attributed should be specified. . We strongly recommend the authors to register and provide Open Researcher and Contributor Identification (ORCID). ID

2. Abstract:

This is the second page of the manuscript. This should be no more than 200 words in length, should summarize the significant findings and should not contain any references.

Original research, systematic reviews, and meta-analyses require structured abstracts. The abstract should provide the context or background for the study and should state the study's purpose, basic procedures (selection of study participants, settings, measurements, analytical methods), main findings and principal conclusions. It should emphasize new and important aspects of the study or observations, important limitations, and not overinterpret findings. Funding sources should be listed separately after the abstract to facilitate proper display and indexing for search retrieval by MEDLINE. The funding statement should include only direct support of the work described. An appropriate funding statement might be: “This study was funded by …… (name of the Funding organization)

3.Keywords

For indexing and search purposes, 6 to 8 keywords can be provided that accurately represent the content of your manuscript. Keywords should be concise, and preferably consist of single words. Avoid using phrases that include conjunctions like “and” or prepositions like “of.” Keywords should be arranged alphabetically with first letter of each word should be capital and each keyword should be separated by “,” (Comma) or “;” (semicolon)

4. Text Headings:

Set first-level headings in the text over to the left, typed all in capitals (upper case) and in bold; begin the text on the following line. Examples of first-level headings will be: Introduction, Materials & Methods, Results, Discussion and References. Second-level headings should be typed with initial capital letter, in small lower-case letters and in bold. For third-level headings, type similarly but not in bold. For fourth-level headings, type similarly but in italics.

• INTRODUCTION Introduction should Provide a context or background for the study (that is, the nature of the problem and its significance). It should State the specific purpose or research objective of, or hypothesis tested by, the study or observation. only directly pertinent references can be cited.
• MATERIALS AND METHODS The Methods section should aim to be sufficiently detailed such that others with access to the data would be able to reproduce the results. In general, the section should include only information that was available at the time the plan or protocol for the study was being written; all information obtained during the study belongs in the Results section. If an organization was paid or otherwise contracted to help conduct the research (examples include data collection and management), then this should be detailed in the methods. The Methods section should include a statement indicating that the research was approved by an independent local, regional or national review body (e.g., ethics committee, institutional review board). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the local, regional or national review body explicitly approved the doubtful aspects of the study. Authors who used AI technology to conduct the study should describe its use in the methods section in sufficient detail to enable replication of the approach. including the tool used, version, and prompts where applicable
• Selection and Description of Participants

  In the case of observational or experimental participants (healthy individuals or patients, including controls), eligibility and exclusion criteria and a description of the source population should be clearly stated. Correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. Authors should use neutral, precise, and respectful language to describe study participants and avoid the use of terminology that might stigmatize participants.

  The study's main and secondary objectives–usually identified as primary and secondary outcomes. Should be specified methods, equipment (give the manufacturer's name and address in parentheses), and procedures should be described in sufficient detail to allow others to reproduce the results. References to established methods, including statistical methods should be provided. All drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration. appropriate scientific names and gene names should be mentioned.

• RESULTS Results should be presented in logical sequence in the text, tables, and figures, giving the main or most important findings first. Quantitative data should be provided not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated. It is advisable to use graphs as an alternative to tables with many entries.” Separate reporting of data by demographic variables, such as age and sex, facilitate pooling of data for subgroups across studies and should be routine, unless there are compelling reasons not to stratify reporting, which should be explained.
• DISCUSSION It is useful to begin the discussion by briefly summarizing the main findings, and explore possible mechanisms or explanations for these findings. The new and important aspects of the study in the context of the totality of the relevant evidence should be emphasized. The limitations of the study and the implications of the findings for future research should be explained.
• CONCLUSION Conclusions should be linked with the goals of the study in particular, distinguishing between clinical and statistical significance, and avoid making statements on economic benefits and costs unless the manuscript includes the appropriate economic data and analyses.

FIRST-LEVEL HEADINGS

Second-level Headings

Third-level Headings

Fourth-level headings

4. Acknowledgements:

Acknowledgements should be included at the end of the text.

5. References:

References are cited in the text by authors' names (et al. should be used for papers authored by more than two persons) and year of publication. If you are citing more than one publication for one year by the same authors, use suffix a, b or c after the year of publication. Some examples are Hamazaki et al., 1995; Benzie and Smith, 1999; Hausman et al., 2002a and Hausman et al., 2002b. However, the reference list at the end of the manuscript must include names of all authors.
All references should be listed alphabetically at the end of the paper. References should list author's last name followed by initial(s), year, and title of the article, full name of the journal (in italics), volume, and inclusive page numbers:

Articles:

Hyun-Sook, K., Hausman, G.J., Hausman, D.B., Martin, R.J. and Dean, R.G. (2000). The Expression of Peroxisome Proliferator-Activated Receptor in Pig Fetal Tissue and Primary Stromal-Vascular Cultures. Obesity Research 8:83-88.

Books:

Spilker, B. and Cramer, J. A. (1992) Patient recruitment in clinical trials, (New York, New York: Raven Press Ltd).

Book Chapters:

Onaivi, E.S., Talton, S. and Prasad, C. (1993) The level of protein in diet modulates the behavioral effects of amphetamine. In: Lehnert, H., Murison, R., Weiner, H., Hellhammer, D. and Beyer, J. (Eds), Endocrine and Nutritional Control of Basic Biological Functions (Toronto: Ontario: Hogrefer & Huber Publishers), pp. 287-292.

Abstracts:

Salahuddin, F., Svec, F. and Dinan, T. G. (1997) Low DHEA levels in patients with chronic fatigue syndrome. Journal of Investigative Medicine 45, 56A (Abstract).

Unpublished results (including articles submitted for publication) or personal communications should be cited as such within the text.

6. Footnotes:

There should be minimal use of footnotes. A footnote may include the designation of a corresponding author of the paper, current address information for an author (if different from that shown in the affiliation), and it will appear at the bottom of the title page. Grant support of research should appear in a separate Acknowledgements section at the end of the paper, not in a footnote. Acknowledgements of the assistance of colleagues or similar note of appreciation also properly belong in an Acknowledgements section, not in footnotes.
Footnotes should be indicated in the text by the following symbols: * (asterisk or star), †(dagger), ‡ (double dagger), ¶ (paragraph mark), § (section mark), II (parallels), # (number sign). Do not use numerals for footnotes call-outs, as they may be mistaken for bibliographical reference call-outs or exponents. Footnotes within a table should be indicated by the same symbols listed above. Type footnotes to a table directly beneath the table.

7. Figure Legends:

All figure legends should be typed on a separate sheet, be numbered with consecutive Arabic numbers, have descriptive legends, and be mentioned in the text. Keep figures separate from the text but indicate an approximate position for each figure in the margin.

8. Illustrations:

The quality of line drawings and photographs must be of a high enough standard for direct reproduction. No additional artwork redrawing or typesetting will be done. Photographs intended for halftone reproductions must be glossy original prints of maximum contrast. Illustrations should be prepared to fit either into a single column width (75 mm) or double column width (160 mm), in the case of line drawings, after 50% reduction. All lettering must be clearly legible and be not less than 4 mm in height.

9. Tables:

Tables should be consecutively numbered with Arabic numbers and have a clear descriptive title at the top. Explanatory table footnotes are acceptable (please also see Footnotes).

10. Abbreviations and Conventions:

Abbreviations that are nonstandard should be defined in the text when first used. Whenever possible restrict the use of abbreviations to SI (Systeme Internationale) symbols.

Peer review Process

All manuscripts published in the CTNR undergo a thorough peer review process. This involves review by 2 independent peer reviewers plus journal’s in-house editor. All submissions to the CTNR are first assessed by an in-house editor, who decides whether the submission meets the scope of the journal, and it is suitably written for peer review. The in-house editor in consultation with the Editor-in-Chief assigns the manuscript to the one of the several editors who assume responsibility as communicating editor for overseeing peer review. The communicating editors are encouraged to seek assistance of statistics editor when there may be complex experimental design. Communicating Editors in consultation with the Editor-in-Chief will decide based on the reviewers’ reports and authors are sent these reports along with the editorial decision (accept, revise, or reject) on their manuscript. Authors of the manuscripts with good science but poor presentation are referred to and advised to choose from one of the many commercial editorial services to revise the manuscript and re-submit mostly as a new manuscript. We follow a close peer review system where reviewers are anonymous, and the pre-publication history is not revealed to authors.

Conflict of Interest Disclosure

It is the policy of this journal and the publisher (New Century Health Publishers, LLC) that readers of the journal should be made aware of any affiliation or financial interest that may affect the author's presentation. Therefore, authors of review articles should disclose at the time of submission any financial arrangement they may have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, the editors will usually discuss with the authors the way such information is to be communicated to the reader.

This information should be provided on a separate sheet of paper under title "Conflict of Interest Disclosure" and included with the manuscript submitted. Please provide your name, signature and the title of the manuscript below the "Conflict of Interest Disclosure" statement. If there is no conflict of interest, simply state so. Editors are not to share this statement with the reviewers of the manuscript.

Experiments dealing with Human Subjects

Research involving human participants, human material, or human data, must have been performed in accordance with the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) and must have been approved by an appropriate institutional review board. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Manuscripts will not be reviewed if the in-house editor considers that the research has not been carried out within an appropriate ethical framework.

Research involving human participants, informed consent to participate in the study must be obtained from participants (or their parent or legal guardian in the case of minors) and a statement to this effect should appear in the manuscript. Consent must be obtained for all forms of personally identifiable data including biomedical, clinical, and biometric data. Documentary evidence of consent must be supplied if requested.

Clinical Trial registration

CTNR supports improved reporting of clinical trials. To this end, authors are recommended to register their clinical trial with Clinical Trial.Gov, US National Library of Medicine (https://clinicaltrials.gov). The trial registration number and date of registration should be included in the manuscript.

Experiments dealing with Animals

Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The fundamental principles to adhere to when conducting research in animals is outlined under IACUC Central (https://www.aalas.org/iacuc). A statement detailing compliance with relevant USA guidelines must be included in the manuscript. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption). Manuscripts will not be reviewed if the in-house editor considers that the research has not been carried out within an appropriate ethical framework of Animal Use and Care.

Experiments dealing with plants and plant-materials.

Experiments dealing with all plants, including the collection of plant material, must comply with institutional, national, or international guidelines. Field studies should be conducted in accordance with local legislation, and the manuscript should include a statement specifying the appropriate permissions and/or licenses. Voucher specimens must be deposited in a public herbarium or other public collection providing access to deposited material. Information on the voucher specimen and who identified it must be included in the manuscript.

Funding Source

A detailed description of the external source of all financial contributions used to fund this research. If there was no external funding received, just state so.

Assurance of The Originality of Data

All author(s) assure the readers and the publishers that all data presented here are original. This can be done by completing a form provided by the publisher.

Contribution of Authors

Each author should describe his or her contribution to this manuscript. Example: The study was conceptualized by Huan Cheng and conducted by Da Zhong and Ninghong Song. Huan Cheng, Huan Cheng Chengjian Ji, Yong Wang, and Yichun Wang contributed to data curation, visualization, analysis, software use and data validation. Yichun Wang, Ninghong Song, and Huan Cheng were responsible for methodology development, resource acquisition, and project administration. Huan Cheng reviewed the literature and prepared the original draft of the manuscript. Ninghong Song acquired funding for this project.

Data Availability

A comprehensive account of the datasets associated with your research should be provided , indicating that all datasets produced or examined during the study are included in the manuscript or are otherwise accessible as supplementary data as part of the publication process. This transparency allows readers and reviewers to verify and build upon your research findings. If your manuscript does not contain any data or if the study did not involve the generation or examination of datasets, simply state “This statement does not apply to this article” in this section.

Including a Data Availability Statement ensures that your research adheres to best practices for open science and supports the reproducibility and transparency of scientific research.

Fidelity and Accuracy of References Used
Authors assure that all references cited are recent, accurate and represent the content of the text. Older references are permitted only in context of historical discussion. Some specific examples:

• Vitamin D metabolites exert anti-proliferative and pro-differentiation effects on PCa cell lines in vitro and in vivo (Gupta et al., 2009). Here, Gupta et al., 2009 must document anti-proliferative and pro-differentiation effects in vitro and in vivo (Gupta et al., 2009). If not use more than on references here.
• Refrain from using secondary references like reviews. As much as possible use a primary reference.